Federal contractor · CAMBRIDGE, MA

TAKEDA PHARMACEUTICALS AMERICA, INC.

TAKEDA PHARMACEUTICALS AMERICA, INC. received $347K in federal contract obligations in FY2026, on 19 awards (−31% vs FY2025). Since FY2019: $4.7M. Its largest customer was Department of Veterans Affairs ($246.5K).

Obligations · FY2026
$347K
New awards
19
Sole-source
0.0%
Single offer
46%
UEI
ENNFDLWFC6L1
Other than small businessForeign-owned

Company family

Grouped from reported parent companies (UEI) and, where marked, AI judgments that two records name the same organization or group.

Part of the TAKEDA PHARMACEUTICALS AMERICA, INC. company family: 2 registered entities, $1.9M in FY2026 together. See the family

  1. TAKEDA PHARMACEUTICALS AMERICA, INC.DEERFIELD, IL · Family page
    $1.6M

AI-inferred: entity-match@1 · Analisa AI · 2026-09-29

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 11.5KFY2019
  2. 758.4KFY2020
  3. 842.6KFY2021
  4. 1MFY2022
  5. 465KFY2023
  6. 712.6KFY2024
  7. 506.2KFY2025
  8. 347KFY2026

Top buying agencies

Obligations in FY2026.

  1. 13 awards
  2. 6 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

  1. Health & medical$347K100%

Where the work was performed

Integrity signals

Shares of the year's obligations, next to the country's.

  • Low competition46%
    US 39% · $159.7K
  • Sole-source awards0.0%
    US 30% · $0
  • Single-offer competitions46%
    US 8.7% · $159.7K
  • Urgency justifications0.0%
    US 5.1% · $0

A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.

Largest awards

  1. Department of Veterans Affairs· St. Louis County, MO· Health & medical· Oct 8, 2024 – Jan 15, 2026· 36C26025F0052
  2. Department of Veterans Affairs· St. Louis County, MO· Health & medical· May 7, 2026 – May 7, 2026· 36C24526N0576
  3. Department of Veterans Affairs· St. Louis County, MO· Health & medical· Feb 20, 2026 – Feb 20, 2026· 36C24526N0336
  4. Federal Prison System / Bureau of Prisons· Orange County, FL· Health & medical· Dec 15, 2025 – Dec 15, 2025· 15B40626F00000025
  5. Department of Veterans Affairs· St. Louis County, MO· Health & medical· Nov 21, 2025 – Nov 21, 2025· 36C24526N0161
  6. Department of Veterans Affairs· Bullitt County, KY· Health & medical· Aug 27, 2026 – Aug 27, 2026· 36C24526N0839
  7. Department of Veterans Affairs· Bullitt County, KY· Health & medical· Jul 31, 2026 – Jul 31, 2026· 36C24526N0787
  8. Department of Veterans Affairs· Bullitt County, KY· Health & medical· Jul 24, 2026 – Jul 24, 2026· 36C24526N0758

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 3 markets (agency × industry), FY2024–FY2026.

  1. ACTELION PHARMACEUTICALS US, INC.$5.3M−8.1% in FY2026
    SOUTH SAN FRANCISCO, CA · 68% of this company's obligations are in markets they both serveVeterans Affairs · Pharmaceutical and medicine manufacturingFederal Prison System / Bureau of Prisons · Pharmaceutical and medicine manufacturing
  2. PHARMALOGIC HOLDINGS CORP.$3.9M+87% in FY2026
    BOCA RATON, FL · 49% of this company's obligations are in markets they both serveVeterans Affairs · Pharmaceutical and medicine manufacturing
  3. SCHAAF DRUGS, LLC$3.8M+121% in FY2026
    LIMA, OH · 48% of this company's obligations are in markets they both serveVeterans Affairs · Pharmaceutical and medicine manufacturing

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026 · FY2024–FY2026.

Lobbying and PAC activity

Organizations in House lobbying disclosures and FEC records whose names an AI judgment matched to this company. Those records carry no identifier shared with contracts, so every match is by name.

Across the company family of TAKEDA PHARMACEUTICALS AMERICA, INC. (2 recipients).

Matched organizations

  • TAKEDA PHARMACEUTICALS AMERICA, INC.AI match · 100%
  • Takeda Pharmaceutical CompanyAI match · 99%
Lobbying · 2025
$4M
32 reports
Lobbying · 2023–2026
$13.6M
$13.5M in its own reports
PAC giving · 2026
$144.5K
1 PAC

Lobbying by year

  1. 2023$4.6M
    29 reports
  2. 2024$2.9M
    23 reports
  3. 2025$4M
    32 reports
  4. 2026$2.1M
    18 reports

Top issues

  1. Health issues69 reports
  2. Medicare and Medicaid57 reports
  3. Taxation and the Internal Revenue Code44 reports
  4. Trade (domestic and foreign)34 reports
  5. Budget and appropriations26 reports
  6. Copyright, patent and trademark14 reports
  7. Defense12 reports
  8. Pharmacy9 reports

Who was contacted

  1. U.S. HOUSE OF REPRESENTATIVES95 reports
  2. U.S. SENATE83 reports

Houses of Congress and federal agencies the reports list as contacted (a report names every one for all its issues).

Lobbying firms hired

  1. Tiber Creek Group$710K
    14 reports
  2. Todd Strategy Group$700K
    14 reports
  3. PORTERFIELD, FETTIG & SEARS, LLC$630K
    13 reports
  4. Crossroads Strategies, LLC$600K
    14 reports
  5. HOLLAND & KNIGHT LLP$470K
    11 reports
  6. ALPINE GROUP PARTNERS, LLC.$280K
    6 reports
  7. B HALL STRATEGIES, LLC$150K
    5 reports
  8. Farragut Partners LLP$80K
    2 reports

11 firms in all. Registrants who are individuals are counted, not named.

PAC giving to candidates by party, 2026 cycle

  1. Democratic$72.5K50%
  2. Republican$72K50%

PACs sponsored

  • TAKEDA PHARMACEUTICALS AMERICA INC. POLITICAL ACTION COMMITTEE$270.7K raised this cycle

PACs these organizations sponsor (connected organizations in FEC records). A PAC gives employees' and members' voluntary contributions, not the company's own money.

Lobbying amounts are the filers' own good-faith estimates on quarterly LD-2 reports (the law asks for amounts rounded to $10,000; under $5,000 need not be itemized), latest amendment only. When an organization files its own report, it replaces what outside firms report for it that quarter. Matches are by name. Lobbying and political giving are legal and public: they show engagement with government, not influence over any award. Correlation is not influence: these organizations' lobbying and their contracts are shown side by side, and nothing here implies either affected the other.

Source: Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives), data current to Oct 10, 2026, loaded Oct 10, 2026 · 2023–2026.

Source: Committees, candidates and committee contributions to candidates (Federal Election Commission), data current to Oct 10, 2026, loaded Oct 10, 2026 · 2026, 2024, 2022.

Matches: Analisa AI name judgments (entity-match@1), updated Oct 9, 2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026.